NCT04092270 2026-05-13A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting54 enrolled